Novo Shortens Name to Boost Recognition in Obesity Market
Product·2 articles across 2 outlets
Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data
Novo Nordisk A/S will shorten its name for day-to-day use to just Novo in a bid to become more recognizable in its obesity market war with Eli Lilly & Co.
This strategic move aims to enhance brand recognition as Novo competes with Eli Lilly in the growing obesity treatment sector.
NovoEli Lilly
Sources
Every quote below is verbatim from the article it is attributed to.
SourceReports the news
“Novo Nordisk A/S will shorten its name for day-to-day use to just Novo in a bid to become more recognizable in its obesity market war with Eli Lilly & Co.”
Bloomberg — Novo Will Use Shorter Name to Boost Recognition in Obesity